Surgery Partners Deal Sets $23.50 Cash Payment for Eligible Shareholders

A $5.7 billion deal for Surgery Partners would pay shareholders other than Bain Capital affiliates $23.50 per share in cash and take the company private after an expected 2027 closing.

The transaction is expected to close in the first quarter of 2027. Surgery Partners would become privately held after the deal closes.

Bayer won its first Roundup trial since the Supreme Court ruling. Bayer said the result creates challenges for plaintiffs. A proposed $7.25 billion settlement covering other lawsuits remains under review.

U.S. stocks also ended the week lower as technology shares sold off following discouraging earnings reports. The S&P 500 fell 1.82%, while the Nasdaq Composite declined 2.86%.